DFDA

Medical Management / Watchful Waiting

Treatment for Non Rheumatic Degenerative Mitral Valve Disease

Typical Dosage: Varies by medication (e.g., Lisinopril 5-40mg daily, Metoprolol 25-200mg daily)

Effectiveness
40%
Safety Score
80%
Clinical Trials
500
Participants
200K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
80
DangerousModerateSafe
Treatment Details
Dosage Range
Varies by medication (e.g., Lisinopril 5-40mg daily, Metoprolol 25-200mg daily)
Time to Effect
Days to weeks for symptom management
Treatment Duration
Lifetime
Evidence Quality
HIGH
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$1,000
Monitoring:$1,500
Side Effect Mgmt:$200
Total Annual:$2,700
Outcome-Based Costs
Cost per Responder
$4,153.85
Medical Management / Watchful Waiting Outcomes

for Non Rheumatic Degenerative Mitral Valve Disease

Efficacy Outcomes
Overall Effectiveness
+40%
Response Rate
+65%
Common Side Effects
Fatigue (from beta-blockers)
+15%
Cough (from ACE inhibitors)
+10%
Dizziness/Hypotension
+7%

Sources:

mitralvalverepair.org
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov